NCT03218904 is a NA clinical trial of Glucose intake in Patient Compliance, sponsored by University of British Columbia.

Who is sponsoring NCT03218904?

NCT03218904 is sponsored by University of British Columbia.

What drugs are being tested in NCT03218904?

Interventions in NCT03218904: Glucose intake, Carbohydrates intake.

What condition does NCT03218904 study?

NCT03218904 studies Patient Compliance, Healthy.

Is NCT03218904 still recruiting?

NCT03218904 is currently completed. Last updated 27 January 2025.

Last reviewed 2025-01-27 · How we verify

NCT03218904

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Glycogen Storage Disease Breath Test Study

Completed NA Last updated 27 January 2025

What this trial tests

NA trial testing Glucose intake in Patient Compliance in 14 participants. Completed in 24 January 2025.

Timeline

17 March 2017

Primary endpoint
23 October 2021

24 January 2025

Quick facts

Lead sponsor	University of British Columbia
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	sequential
Masking	none
Primary purpose	health services research
Enrollment	14
Start date	17 March 2017
Primary completion	23 October 2021
Estimated completion	24 January 2025
Sites	1 location across Canada

Drugs / interventions tested

Glucose intake
Carbohydrates intake

Conditions studied

Patient Compliance — all drugs for Patient Compliance →
Healthy — all drugs for Healthy →

Sponsor

University of British Columbia

Who can join

Adults 5 to 35, any sex, with Patient Compliance or Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Glycogen storage disease type I (GSD I) caused by deficiency of glucose-6-phosphatase enzyme leading to build up of a complex sugar called glycogen in liver and low blood glucose level. Nutritional treatment involves supplying carbohydrates and uncooked cornstarch. Glycosade® (modified cornstarch) has shown promise in maintaining normal blood glucose level in GSD I. But the difficulty in nutritional treatment is determining the best type of carbohydrate to be given to avoid low blood glucose. Thus, there is a need to develop a simple test to examine glucose digestion and measure the utilization of different carbohydrates in GSD I and healthy controls.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Development of minimally invasive <sup>13</sup>C-glucose breath test to examine different exogenous carbohydrate sources in patients with glycogen storage disease type Ia.
Turki A, Stockler S, Sirrs S, Salvarinova R, et al · · 2022 · cited 1× · PMID 35585965 · DOI 10.1016/j.ymgmr.2022.100880

Verify or expand the search:

Other trials of Glucose intake

Trials testing the same drug.

NCT03173677 — Macrophage Polarization in Response to Macronutrient Intake in Healthy Humans: A Randomized Clinical Study · NA · completed

Other recruiting trials for Patient Compliance

Currently open trials in the same condition.

NCT04656028 — Genetic Testing and Motivational Counseling for FH · NA · active not recruiting
NCT06076512 — Pain Clinic Provides Public Health Safety · recruiting

Other University of British Columbia trials

Trials by the same sponsor.

NCT07340970 — Sensory Stimuli During Cesarean Delivery · not yet recruiting
NCT07481201 — Phenylalanine Requirements in the Menstrual Phases · NA · not yet recruiting
NCT07492095 — Leucine Requirements in School-Age Children · NA · not yet recruiting
NCT07429305 — Combined Tibial Nerve Stimulation and Standing for People With SCI · NA · recruiting
NCT07519928 — Exploring the Feasibility and Benefits of Implementing Pelvic Floor Muscle Training During Inpatient Rehabilitation for · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03218904 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of British Columbia
Last refreshed: 27 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03218904.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing